Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Dakopatts AB

Below is an extended Dakopatts AB news listing. Click here to return to the Dakopatts AB main Biocorporate entry.

BioNews Results for Dakopatts AB:
Diagnostic Hybrids Announces FDA Clearance of D3(R) FastPointTM L-DFATM Influenza A/ Influenza B Virus Identif Pharmacy Choice: Nov 15 2009 4:54PM Matching: ab
BioInvent Signs Licensing Agreement with Daiichi Sankyo for the Discovery and Development of Therapeutic Antib PharmiWeb: Nov 15 2009 3:26AM Matching: ab
Axelar AB Presents the New Anticancer Agent AXL1717 at The AACR-NCI-EORTC International Conference on Molecula KOTA Territory News: Nov 14 2009 11:05PM Matching: ab
Axelar AB Presents the New Anticancer Agent AXL1717 at The AACR-NCI-EORTC International Conference on Molecula KSLA: Nov 14 2009 7:28AM Matching: ab
GM: 37 pct of US Saab dealerships to close Research & Development: Nov 14 2009 7:48PM Matching: ab
LU Bioscience increases position in ProNoxis Bionity.com: Nov 14 2009 6:30PM Matching: ab
Merck Eprova and Isofol Medical Enter Exclusive Agreement for Merck Eprova's Modufolin in oncology Bionity.com: Nov 14 2009 6:29PM Matching: ab
Axelar AB to present data from ongoing Phase I/II clinical trial concerning AXL1717 News-Medical.Net: Nov 13 2009 2:28PM Matching: ab
LU Bioscience (SE) - LU Bioscience increases position in ProNoxis Pharma Live: Nov 13 2009 3:51AM Matching: ab
Axelar AB Presents the New Anticancer Agent AXL1717 at The AACR-NCI-EORTC International Conference on Molecula St Louis Business Journal: Nov 13 2009 12:53PM Matching: ab
Axelar AB Presents the New Anticancer Agent AXL1717 at The AACR-NCI-EORTC International Conference on Molecula Birmingham Business Journal: Nov 13 2009 11:35AM Matching: ab
Axelar AB Presents the New Anticancer Agent AXL1717 at The AACR-NCI-EORTC International Conference on Molecula Business Journal of Milwaukee: Nov 13 2009 11:31AM Matching: ab
Axelar AB Presents the New Anticancer Agent AXL1717 at The AACR-NCI-EORTC International Conference on Molecula Denver Business Journal: Nov 13 2009 11:28AM Matching: ab
Axelar AB Presents the New Anticancer Agent AXL1717 at The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston, Massachusetts, USA Earthtimes.org: Nov 13 2009 11:17AM Matching: ab
Axelar AB Presents the New Anticancer Agent AXL1717 at The AACR-NCI-EORTC International Conference on Molecula Reuters: Nov 13 2009 10:24AM Matching: ab

«Dakopatts AB

This page contained an extended Dakopatts AB news listing. Click here to return to the Dakopatts AB main Biocorporate entry.

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.